| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 1, no: 10 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4ICU9
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 101 | 103 | PF00675 | 0.499 |
| CLV_NRD_NRD_1 | 147 | 149 | PF00675 | 0.628 |
| CLV_NRD_NRD_1 | 150 | 152 | PF00675 | 0.662 |
| CLV_NRD_NRD_1 | 30 | 32 | PF00675 | 0.504 |
| CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.504 |
| CLV_PCSK_KEX2_1 | 99 | 101 | PF00082 | 0.517 |
| CLV_PCSK_PC1ET2_1 | 99 | 101 | PF00082 | 0.517 |
| CLV_PCSK_PC7_1 | 26 | 32 | PF00082 | 0.509 |
| CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.514 |
| DOC_USP7_MATH_1 | 112 | 116 | PF00917 | 0.666 |
| DOC_USP7_MATH_1 | 62 | 66 | PF00917 | 0.711 |
| DOC_USP7_MATH_1 | 70 | 74 | PF00917 | 0.652 |
| DOC_USP7_MATH_1 | 86 | 90 | PF00917 | 0.601 |
| DOC_USP7_UBL2_3 | 145 | 149 | PF12436 | 0.578 |
| DOC_WW_Pin1_4 | 113 | 118 | PF00397 | 0.749 |
| DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.713 |
| DOC_WW_Pin1_4 | 60 | 65 | PF00397 | 0.657 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.607 |
| LIG_SH2_STAT3 | 75 | 78 | PF00017 | 0.750 |
| LIG_SH2_STAT3 | 90 | 93 | PF00017 | 0.420 |
| LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.740 |
| LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.495 |
| LIG_SH3_3 | 118 | 124 | PF00018 | 0.741 |
| LIG_UBA3_1 | 91 | 99 | PF00899 | 0.600 |
| MOD_CK1_1 | 63 | 69 | PF00069 | 0.686 |
| MOD_CK1_1 | 71 | 77 | PF00069 | 0.690 |
| MOD_CK2_1 | 138 | 144 | PF00069 | 0.579 |
| MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.696 |
| MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.634 |
| MOD_GlcNHglycan | 70 | 73 | PF01048 | 0.622 |
| MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.605 |
| MOD_GSK3_1 | 104 | 111 | PF00069 | 0.657 |
| MOD_GSK3_1 | 49 | 56 | PF00069 | 0.654 |
| MOD_PIKK_1 | 123 | 129 | PF00454 | 0.767 |
| MOD_PIKK_1 | 132 | 138 | PF00454 | 0.752 |
| MOD_PIKK_1 | 80 | 86 | PF00454 | 0.625 |
| MOD_Plk_1 | 138 | 144 | PF00069 | 0.672 |
| MOD_Plk_1 | 56 | 62 | PF00069 | 0.736 |
| MOD_Plk_4 | 49 | 55 | PF00069 | 0.723 |
| MOD_Plk_4 | 86 | 92 | PF00069 | 0.620 |
| MOD_ProDKin_1 | 113 | 119 | PF00069 | 0.752 |
| MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.716 |
| MOD_ProDKin_1 | 60 | 66 | PF00069 | 0.659 |
| TRG_ER_diArg_1 | 100 | 102 | PF00400 | 0.491 |
| TRG_ER_diArg_1 | 29 | 31 | PF00400 | 0.519 |
| TRG_NLS_MonoExtC_3 | 147 | 152 | PF00514 | 0.633 |
| TRG_NLS_MonoExtN_4 | 145 | 152 | PF00514 | 0.634 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P7D8 | Leptomonas seymouri | 50% | 81% |
| A0A0S4JKZ0 | Bodo saltans | 40% | 100% |
| A0A1X0P8A6 | Trypanosomatidae | 32% | 100% |
| A0A3S7XA93 | Leishmania donovani | 100% | 100% |
| A0A422P2F7 | Trypanosoma rangeli | 43% | 100% |
| A4HNP6 | Leishmania braziliensis | 73% | 96% |
| D0A2K4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
| E9ASF5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
| Q4Q240 | Leishmania major | 92% | 100% |
| V5BV99 | Trypanosoma cruzi | 44% | 100% |